Insulin Resistance and Cancer [recurso electrónico] : Epidemiology, Cellular and Molecular Mechanisms and Clinical Implications / edited by I. George Fantus.

Por: Fantus, I. George [editor.]Colaborador(es): SpringerLink (Online service)Tipo de material: TextoTextoSeries Energy Balance and Cancer ; 1Editor: New York, NY : Springer New York, 2011Descripción: XII, 300 p. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9781441999115Tema(s): Medicine | Oncology | Toxicology | Biomedicine | Cancer Research | Pharmacology/ToxicologyFormatos físicos adicionales: Printed edition:: Sin títuloClasificación CDD: 614.5999 Clasificación LoC:RC261-271Recursos en línea: Libro electrónicoTexto
Contenidos:
Insulin and the Physiology of Carbohydrate and Lipid Metabolism -- Insulin Signalling: Cellular and Molecular Mechanisms -- Mechanisms of Insulin Resistance, Obesity and Metabolic Syndrome -- Obesity and Cancer: Epidemiology -- Insulin, Insulin Resistance and Cancer Associations -- Animal Models of Hyperinsulinemia, Insulin Resistance and Cancer -- Actions of Insulin as a Survival and Growth Factor: Akt/PKB, mTOR and MAPK Signaling -- Potential Mechanisms Linking Insulin to Cancer -- Insulin-like Growth Factors and Cancer -- Insulin, IGF Receptors and Cancer -- Clinical Implications for Cancer Treatment and Prevention.
En: Springer eBooksResumen: This book reviews the epidemiological associations between insulin resistance and cancer. This is followed by reviews of animal models which support this relationship and provide insight into potential mechanisms. Several chapters then provide detailed examination of the cellular and molecular changes characterizing the insulin resistant state, such as hyperinsulinemia, abnormal metabolism and hormone signaling, and how these interact with various tumor characteristics. For example some tumors present increased quantities of the fetal form of the insulin receptor, unique regulation of oxidative (Krebs’ cycle) metabolism (Warburg effect), as well as mutations in various relevant signaling pathways. Finally, the clinical implications of these data are integrated with considerations of insulin “sensitization” and potential metabolic interventions to prevent and treat cancer. It should be noted that while a number of cancers are associated with obesity the authors here have focused primarily on breast cancer as a key and significant model.
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos RC261 -271 (Browse shelf(Abre debajo)) 1 No para préstamo 372330-2001

Insulin and the Physiology of Carbohydrate and Lipid Metabolism -- Insulin Signalling: Cellular and Molecular Mechanisms -- Mechanisms of Insulin Resistance, Obesity and Metabolic Syndrome -- Obesity and Cancer: Epidemiology -- Insulin, Insulin Resistance and Cancer Associations -- Animal Models of Hyperinsulinemia, Insulin Resistance and Cancer -- Actions of Insulin as a Survival and Growth Factor: Akt/PKB, mTOR and MAPK Signaling -- Potential Mechanisms Linking Insulin to Cancer -- Insulin-like Growth Factors and Cancer -- Insulin, IGF Receptors and Cancer -- Clinical Implications for Cancer Treatment and Prevention.

This book reviews the epidemiological associations between insulin resistance and cancer. This is followed by reviews of animal models which support this relationship and provide insight into potential mechanisms. Several chapters then provide detailed examination of the cellular and molecular changes characterizing the insulin resistant state, such as hyperinsulinemia, abnormal metabolism and hormone signaling, and how these interact with various tumor characteristics. For example some tumors present increased quantities of the fetal form of the insulin receptor, unique regulation of oxidative (Krebs’ cycle) metabolism (Warburg effect), as well as mutations in various relevant signaling pathways. Finally, the clinical implications of these data are integrated with considerations of insulin “sensitization” and potential metabolic interventions to prevent and treat cancer. It should be noted that while a number of cancers are associated with obesity the authors here have focused primarily on breast cancer as a key and significant model.

19

Con tecnología Koha